Travere Therapeutics, Inc. ($TVTX)
Filing Information
| Accession Number | 0001283303-26-000001 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 21, 2026 |
| Document Date | Jan 20, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
30,000
Total Value
$464,220.00
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Legal Officer and GC | Common Stock | โ | Jan 20, 2026 | Exercise/Conversion | 10,000 | $19.08 | $190,800.00 | 100,270 | Direct | โ | View Details | |
Chief Legal Officer and GC | Common Stock | โ | Jan 20, 2026 | Sale | 10,000 | $27.34 | $273,420.00 | 90,270 | Direct | โ | View Details | |
Chief Legal Officer and GC | Employee stock option (right to buy) | Derivative | Jan 20, 2026 | Exercise/Conversion | 10,000 | $0.00 | $0.00 | 30,000 | Direct | โ | View Details |